LEO PHARMA

Company Introduction: LEO Pharma India

LEO Pharma is a global healthcare company with a strong presence in India. Headquartered in Ballerup, Denmark, LEO Pharma is dedicated to advancing the standard of care for people with skin diseases and thrombosis.

Factory or Trader:

LEO Pharma in India operates primarily as a pharmaceutical manufacturer (factory). It develops, produces, and markets its specialized dermatological and thrombotic products. While it manufactures, it also engages in the trade and distribution of its proprietary medicines within the Indian market. Therefore, it functions as both a manufacturer and a distributor of its pharmaceutical products.

Company Overview:

LEO Pharma India is a subsidiary of the global LEO Pharma group. The company is focused on delivering innovative therapies to improve the lives of patients suffering from a wide range of dermatological conditions, including psoriasis, eczema, and skin infections, as well as thrombosis. LEO Pharma is committed to research and development to bring new and effective treatments to patients. Its operations in India include sales, marketing, and distribution, supporting its global mission to be a leader in medical dermatology.

LEO Pharma India produces or sells the following products:

1. Daivobet Ointment / Gel (calcipotriol and betamethasone) - for psoriasis

2. Enstilar Foam (calcipotriol and betamethasone) - for psoriasis

3. Fucidin Cream / Ointment (fusidic acid) - for bacterial skin infections

4. Finacea Gel (azelaic acid) - for rosacea and acne

5. Innohep (tinzaparin) - for thrombosis (low molecular weight heparin)

6. Kyntheum (brodalumab) - for moderate to severe plaque psoriasis